Publication: The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation study of the Thai version
4
Issued Date
2006-02-01
Resource Type
ISSN
09629343
Other identifier(s)
2-s2.0-30744457314
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Quality of Life Research. Vol.15, No.1 (2006), 167-172
Suggested Citation
Chatchawan Silpakit, Suwanee Sirilerttrakul, Manmana Jirajarus, Thitiya Sirisinha, Ekaphop Sirachainan, Vorachai Ratanatharathorn The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation study of the Thai version. Quality of Life Research. Vol.15, No.1 (2006), 167-172. doi:10.1007/s11136-005-0449-7 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/23825
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation study of the Thai version
Other Contributor(s)
Abstract
The objective of this study was to assess the psychometric properties of the Thai version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) version 3.0. The questionnaire was completed by 310 cancer patients during their follow-up at 2 teaching hospital oncology clinics. About 70% of participants had advanced stage of cancer and 72% had been receiving chemotherapy. Cronbach's α coefficients of the six scales were above 0.7, except for cognitive and social function scales. All test-retest reliability coefficients were high. Multitrait scaling analysis showed that all item-scale correlation coefficients met the standards of convergent and discriminant validity. Most scales and items could discriminate between subgroups of patients with different clinical status assessed with the Eastern Cooperative Oncology Group (ECOG) scale. The results suggested that the EORTC QLQ-C30 and the Functional Assessment of Cancer Therapy - General (FACT-G) measured different aspects of quality of life and should be independently used. Testing psychometric properties of the EORTC QLQ-C30 in heterogeneous diagnostic group yield similar results as found in homogeneous group. These results support that the EORTC QLQ-C30 (version 3.0) has proven to be a reliable and valid measure of the quality of life in Thai patients with various types of cancer. © Springer 2006.